Feasibility study of the immunogenicity and safety of a novel DTPw/Hib (PRP-T) Brazilian combination compared to a licensed vaccine in healthy children at 2, 4, and 6 months of age
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.